Emerging data indicate that SARS-CoV-2-specific CD8+ T cells targeting different viral
proteins are detectable in up to 70% of convalescent individuals,,,–. However, very little …

Background A longitudinal study was performed to determine the breadth, kinetics, and
correlations of systemic and mucosal antibody responses to severe acute respiratory …

T-cell immunity is likely to play a role in protection against SARS-CoV-2 by helping generate
neutralizing antibodies. We longitudinally studied CD4 T-cell responses to the M, N, and S …

This study examined whether CD8+ T-cell responses from coronavirus disease 2019
convalescent individuals (n= 30) potentially maintain recognition of the major severe acute …

Backgrounds SARS-CoV-2 infection results in a broad spectrum of clinical outcomes,
ranging from asymptomatic to severe symptoms and death. Most COVID-19 pathogenesis is …

With a global tally of more than 500 million cases of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections to date, there are growing concerns about the post …

Introduction The longevity of antibody levels against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and the duration of immunity are current topics of major …

BACKGROUND Patients infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) differ in the severity of disease. We hypothesized that characteristics of SARS …

The contribution of CD4+ T cells to protective or pathogenic immune responses to SARS-
CoV-2 infection remains unknown. Here, we present single-cell transcriptomic analysis of> …

Abstract Background The SARS-CoV-2 pandemic currently prevails worldwide. To
understand the immunological signature of SARS-CoV-2 infections and aid the search and …